Ranolazine

CHEMBL1404 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

427.5 g/mol

LogP

2.7

Phase

4

An antianginal medication used to treat chronic chest pain (angina) in patients who remain symptomatic despite other heart medications, working through a unique mechanism that improves blood flow to the heart. It does not lower heart rate or blood pressure significantly, making it suitable as an add-on therapy.

Moleküler Ağırlık

427,5000 g/mol

LogP

2,70

TPSA

74,30 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Pain Management Inflammatory Bowel Disease Type 2 Diabetes Hypertension Chronic Pain Heart Failure Atrial Fibrillation Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1

InChI

InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)

Molecular Formula

C24H33N3O4

HBD / HBA

2 / 6

Döndürülebilir Bağlar

9

Ağır Atomlar

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antianginal medication used to treat chronic chest pain (angina) in patients who remain symptomatic despite other heart medications, working through a unique mechanism that improves blood flow to the heart. It does not lower heart rate or blood pressure significantly, making it suitable as an add-on therapy.

Yes, Ranolazine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1404. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 56959. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Ranolazine PillFYI'da

Yapı

Hızlı Veriler

Formül: C24H33N3O4
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.